SHR2554 as Maintenance Therapy in Patients With Peripheral T-cell Lymphoma

by palligoelme@gmail.com | Jan 16, 2026 | Clinical Trials

​ Conditions: PTCL Interventions: Drug: SHR2554 Tablets Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting Conditions: PTCL Interventions: Drug: SHR2554 Tablets Sponsors: The First Affiliated Hospital with Nanjing Medical...

Postoperative Complications After Neoadjuvant Chemoradiotherapy or Short-course Radiotherapy and Total Neoadjuvant Treatment: a Multicentric Retrospective Cohort Study

by palligoelme@gmail.com | Jan 16, 2026 | Clinical Trials

​ Conditions: Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery Interventions: Procedure: Chemoradiotherapy Sponsors: Istituto Clinico Humanitas Enrolling by invitation Conditions: Adult Patients With Locally Advanced...

Multimodal VR Rehabilitation for Cardiorespiratory Fitness in CABG Phase II

by palligoelme@gmail.com | Jan 16, 2026 | Clinical Trials

​ Conditions: CABG Interventions: Other: multimodal circuit training while viewing nature scenes through VR in a clinical setting; Other: multimodal circuit training in a real-world clinical setting; Other: multimodal circuit training through telerehabilitation...

GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial)

by palligoelme@gmail.com | Jan 15, 2026 | Clinical Trials

​ Conditions: Pulmonary Hypertension (Diagnosis); Pre-operative Assessment; Postoperative Complications (Cardiopulmonary); Treatment Outcomes Interventions: Diagnostic Test: Artificial Intelligence-Enabled Electrocardiography System Sponsors: Taipei Veterans General...

[Trial of device that is not approved or cleared by the U.S. FDA]

by palligoelme@gmail.com | Jan 15, 2026 | Clinical Trials

​ Sponsors: [Redacted] Withheld Sponsors: [Redacted] Withheld 

Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function

by palligoelme@gmail.com | Jan 15, 2026 | Clinical Trials

​ Conditions: Chronic Hepatitis B Infection Interventions: Drug: Pevifoscorvir Sodium (ALG-000184) Sponsors: Aligos Therapeutics Not yet recruiting Conditions: Chronic Hepatitis B Infection Interventions: Drug: Pevifoscorvir Sodium (ALG-000184) Sponsors: Aligos...